COVID-19 pandemic Sanofi and GlaxoSmithKline delays a launch of adjuvanted recombinant protein-based of COVID-19 vaccine programme until end of 2021. Sanofi, GSK announce delay in Covid-19 vaccine until end of 2021 © France 24 Sources: France 24